Clinical Trial Update: Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the efficacy and safety of Ecabet Ophthalmic Solution for dry eye syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Ecabet Ophthalmic Solution (ecabet)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED